Last reviewed: September 10, 2026 | International B2B beauty brands
For a beauty brand selling across borders, the first question is not “Where do I register the product?” It is: which party has which obligation in each destination, at what point, and for the exact formula, claims and pack? This guide compares five widely used official pathways. It is a launch-planning overview, not legal advice.
Registration, notification, listing and approval are different
| Term | What it usually means | What it does not prove |
|---|---|---|
| Notification | Information is filed with an authority or portal. | That the authority approved every aspect of the product. |
| Facility registration | A manufacturing or processing site is recorded. | That a specific product is approved or compliant worldwide. |
| Product listing | A product or formula-related record is filed. | That marketing claims or labels were pre-approved. |
| Approval | A formal authorisation where a law requires it. | A general term to use for ordinary cosmetic notification. |
Country-by-country comparison
| Market | Official pathway in brief | Who should own the check |
|---|---|---|
| European Union | Before placing a cosmetic on the EU market, the Responsible Person submits required information through CPNP. The Commission states that once notified, further national notification is not needed within the EU. | EU Responsible Person, supported by the brand and manufacturer. |
| Great Britain | The UK Responsible Person must notify OPSS before the product is made available to consumers in GB and keep the PIF and safety assessment arrangements in place. | GB Responsible Person. |
| Canada | Manufacturers and importers notify Health Canada within 10 days after first sale, and revisions are needed when required information becomes inaccurate. | Canadian manufacturer or importer. |
| United States | MoCRA requires certain facilities to register and responsible persons to list marketed products; exemptions can apply. Registration/listing is not cosmetic approval. | Facility operator and the U.S. label responsible person, as applicable. |
| Australia | AICIS regulates the introduction of industrial-chemical ingredients in cosmetics. A business importing ready-made cosmetics for sale generally needs registration before import; category and records depend on the introduction. | Australian importer/introducer, with product-safety and other obligations checked separately. |
European Union: CPNP is a pre-market notification system
Under the European Commission’s CPNP guidance, Regulation (EC) No 1223/2009 requires Responsible Persons—and in certain circumstances distributors—to submit product information through CPNP when placing or making a product available on the EU market. CPNP is free to use and is not an EU product approval certificate. The EU file must also support the legal framework for the exact product, including the Responsible Person, Product Information File, safety assessment, labelling, claims and GMP.
Great Britain: Responsible Person, PIF and SCPN
For GB, the Responsible Person must have a UK-established address and is responsible for legal obligations. GOV.UK says the Responsible Person should keep an up-to-date PIF, ensure a suitably qualified safety assessment, ensure GMP and notify OPSS before making the product available. Treat GB separately from the EU: do not assume an EU notification automatically completes the GB process.
Canada: notification follows first sale
Health Canada’s guidance says manufacturers and importers must submit a Cosmetic Notification Form within 10 days of the first sale in Canada. The same guidance explains that information changes—such as a formula, product name or contact change—can trigger a revised notification. This is a notification model, not a substitute for checking the Cosmetic Regulations, ingredients, labelling and classification.
United States: MoCRA registration and listing are not approval
FDA explains that manufacturers and processors required to register facilities renew biennially, and a responsible person lists each marketed cosmetic product and provides updates annually. FDA also makes a critical distinction: it does not issue certificates verifying registration or listing, and a number does not indicate FDA approval. Separate safety, labelling, adverse-event and product-classification duties still apply. Claims that make a product a drug or a combination product require a different assessment.
Australia: start with the importer and ingredients
AICIS explains that it regulates the import and manufacture of industrial chemical ingredients used in cosmetics, while therapeutic products and therapeutic claims may fall to the TGA. A business importing ready-made cosmetics for sale in Australia must generally register with AICIS before import, regardless of quantity; AICIS categorisation, reporting and record keeping then depend on the introduction. AICIS also makes clear that it registers the business, not a cosmetic product as an “approved product.”
Build one reusable launch dossier
| Core file | Why it is reusable | Market-specific overlay |
|---|---|---|
| Formula version, INCI list and supplier evidence | Supports ingredient review and accurate notifications. | Restrictions, permitted uses and local naming rules. |
| Safety and quality evidence | Supports the product’s safety rationale and due diligence. | Qualified assessor, PIF or local record requirements. |
| Final label and claims dossier | Keeps the marketed product tied to evidence. | Language, warnings, local address and claims classification. |
| Batch and change-control records | Supports traceability, corrections and post-market actions. | Who files amendments, reports or notifications. |
A practical launch sequence
- Freeze the intended formula, claims and packaging revision.
- Map each target country to its actual market operator: Responsible Person, importer, facility operator or introducer.
- Confirm whether the product remains a cosmetic under local intended-use and claim rules.
- Prepare the technical file and final label before submitting a notification or listing.
- File at the correct point: before sale, after first sale or before import, depending on the market.
- Keep a change log. A new fragrance, shade, claim or legal entity may change the filing route.
Common mistakes
- Calling every official filing “product approval.”
- Using an EU CPNP notification as proof of GB, Canadian, U.S. or Australian compliance.
- Letting a factory file using an unapproved final label or formula version.
- Forgetting that the importer or local Responsible Person can hold key legal duties.
- Assuming “natural,” “organic” or “registered overseas” removes ingredient or claim review.
Official sources
| Authority | Current reference |
|---|---|
| European Commission | CPNP guidance |
| GOV.UK / OPSS | Making cosmetics available in Great Britain |
| Health Canada | Guide for cosmetic notifications |
| U.S. FDA | Registration and listing of facilities and products |
| AICIS | Cosmetic products and industrial chemicals |
FAQ
Do I need one global cosmetic registration?
No. Each destination has its own legal framework and filing point. Use a country matrix rather than a single global claim.
Does notification equal approval?
Usually no. Notification provides information through a legal channel; it should not be marketed as authority endorsement unless the authority explicitly says otherwise.
Who files: the manufacturer or the brand?
It depends on the market and the legal role. Contract documents should identify the actual Responsible Person, importer, responsible person or introducer before launch.
When should an existing filing be updated?
Review the route whenever formula, product name, claims, pack, contact details or market operator changes. Official deadlines can differ by market.
Regulatory requirements may change. Verify current requirements with the relevant authority or a qualified compliance professional before placing cosmetics on the market.